Health ❯ Obesity ❯ Weight Loss ❯ Pharmaceuticals

GLP-1 Drugs

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

A $149 starter offer alongside a January U.S. launch positions the daily tablet to broaden access.

FDA Posts More Than 100 Warning Letters in Drug Ad Crackdown, Targeting Hims, Lilly and Novo